Literature DB >> 16601087

Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation.

B Yates1, D M Murphy, A J Fisher, F K Gould, J L Lordan, J H Dark, P A Corris.   

Abstract

Pseudomembranous colitis is an uncommon complication in patients with cystic fibrosis, despite the use of multiple high-dose antibiotic regimens and the frequency of hospital admissions. Four patients from a total of 137 patients with cystic fibrosis undergoing lung transplantation are described who developed fulminant pseudomembranous colitis. Initial presentation was variable and the mortality rate was 50% despite urgent colectomy. In one case the presenting abdominal distension was thought to be due to meconium ileus equivalent. It is concluded that Clostridium difficile colitis may be a difficult diagnosis in patients with cystic fibrosis and follows a fulminant course after lung transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16601087      PMCID: PMC2117205          DOI: 10.1136/thx.2005.048652

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis.

Authors:  S L Peach; S P Borriello; H Gaya; F E Barclay; A R Welch
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis.

Authors:  L A Binkovitz; E Allen; D Bloom; F Long; S Hammond; C Buonomo; L F Donnelly
Journal:  AJR Am J Roentgenol       Date:  1999-02       Impact factor: 3.959

3.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 4.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

Review 5.  Clostridium difficile--Associated diarrhea: A review.

Authors:  E Mylonakis; E T Ryan; S B Calderwood
Journal:  Arch Intern Med       Date:  2001-02-26

Review 6.  Colonic disorders in adult cystic fibrosis.

Authors:  H Chaun
Journal:  Can J Gastroenterol       Date:  2001-09       Impact factor: 3.522

7.  Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis.

Authors:  J Rivlin; A Lerner; A Augarten; M Wilschanski; E Kerem; M A Ephros
Journal:  J Pediatr       Date:  1998-01       Impact factor: 4.406

8.  Antibiotic-associated colitis and cystic fibrosis.

Authors:  C S Pokorny; P T Bye; C MacLeod; W S Selby
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

9.  Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.

Authors:  Mark H Wilcox; Jane Freeman; Warren Fawley; Sarah MacKinlay; Alex Brown; Katrina Donaldson; Oliver Corrado
Journal:  J Antimicrob Chemother       Date:  2004-05-26       Impact factor: 5.790

  9 in total
  3 in total

1.  Clostridium difficile colitis in solid organ transplantation--a single-center experience.

Authors:  I Stelzmueller; H Goegele; M Biebl; S Wiesmayr; N Berger; W Tabarelli; E Ruttmann; J Albright; R Margreiter; M Fille; H Bonatti
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Indications and Relative Utility of Lower Endoscopy in the Management of Clostridium difficile Infection.

Authors:  Nora E Burkart; Mary R Kwaan; Christopher Shepela; Robert D Madoff; Yan Wang; David A Rothenberger; Genevieve B Melton
Journal:  Gastroenterol Res Pract       Date:  2011-10-17       Impact factor: 2.260

3.  Clostridium difficile infection in cystic fibrosis: an uncommon but life-threatening complication.

Authors:  Francesco Piccolo; Anna Sze Tai; Hooi Ee; Siobhain Mulrennan; Scott Bell; Gerard Ryan
Journal:  Respirol Case Rep       Date:  2016-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.